14:36 Tue 17 Sep 2019
Qrons Inc (OTCQB: QRON) CEO Jonah Meer tells Proactive the New York-based biotechnology company is developing two products, one of which involves a 3D-printable scaffold, aimed at helping to treat traumatic brain injuries.
Meer says that traumatic brain injuries are the number one cause of death among young adults in the US, adding that the company is working towards an Investigational New Drug application or a Biologics Licence application for its products to the FDA.
Price: 1.45 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Director Interviews
Director Interviews
Merck & Co (NYSE:MRK) Head of Pacific Business Development & Licensing Hub and President of the MRL Ventures Fund Reza Halse sat down with Proactive at the BIO Investor Forum in San Francisco. Halse says he's seeing a 'coming of age' in neuroscience, especially seeing an...
Industry & services
